Evidence map›Paper›PMID 38653875›Full record

Observational studyClinical and experimental medicine2024

Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study.

Netanella Danielli Miller, Nitzan Goren Gepstein, Dovev Cohen, Einat Haikin Herzberger, Hila Shalev Ram, Jordana Mashiach Friedler, Maya Sharon Weiner, Roni Rahav, Victoria Indenbaum, Yaniv Lustig and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Clinical and experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Netanella Danielli MillerIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel. millerne@me.com.
Nitzan Goren GepsteinIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Dovev CohenIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Einat Haikin HerzbergerIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Hila Shalev RamIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Jordana Mashiach FriedlerIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Maya Sharon WeinerIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Roni RahavIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.
Victoria IndenbaumCentral Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Tel Aviv, Israel.
Yaniv LustigCentral Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Tel Aviv, Israel.
Amir WiserIVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, 4428164, Kfar Saba, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough there are some data regarding the COVID-19 vaccine and in in vitro fertilization (IVF) treatments, its potential impact in terms of serum immunoglobulin G (IgG) levels has not been evaluated prospectively. This study aimed to assess the effect of COVID-19 vaccine and IgG levels on IVF outcomes.

methodsThis observational, cohort study was conducted at a referral IVF unit. Couples undergoing IVF treatment during the COVID-19 vaccination period were recruited from March-April 2021. The study compared 38 women who had received the Pfizer mRNA COVID-19 vaccination to 10 women who had not and were not infected by the virus. We also compared pre- and post-vaccination IVF treatments for 24 women. The relation between serologic titers and IVF treatment outcomes was also assessed.

resultsNo significant difference was found between the vaccinated and unvaccinated/uninfected groups regarding the main outcome measures. However, there was a trend toward a higher pregnancy rate for the unvaccinated group (57% vs. 23%, p = 0.078) but no difference in delivery rate (p = 0.236), gestational week (p = 0.537) or birth rate (p = 0.671).

conclusionWe cautiously state that the COVID-19 mRNA vaccine does not affect fertility outcomes, including fertilization, pregnancy and delivery rates, obstetric outcomes, and semen parameters, regardless of measured IgG levels.

Indexed as

COVID-19COVID-19 VaccinesFertilization in VitroImmunoglobulin GSARS-CoV-2AdultAntibodies, ViralCohort StudiesFemaleHumansMalemRNA VaccinesPregnancyPregnancy RateAntibodies, ViralCOVID-19 VaccinesImmunoglobulin GmRNA VaccinesCorona virusIn vitro fertilizationmRNA COVID-19 vaccineSemen

Identifiers

PMID38653875
PMCPMC11039503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.